On March 15, President Joe Biden signed a $ 1.5 trillion omnibus spending bill to fund the federal government through September. The bill, as passed, includes a provision amending the definition of “tobacco product” in Section 201 (rr) of the Federal Food, Drug, and Cosmetic Act (“FDCA”) as “any product made or derived from tobacco, or containing nicotine from any source, that is intended for human consumption. ” 21 USC 321 (yy). Now that it is law, this provision closes the synthetic nicotine “loophole” and puts synthetic nicotine products under the US Food and Drug Administration’s (FDA) tobacco regulatory authority.

The law will become effective 30 days after the bill’s enactment, iehe April 14, 2022 (“Effective Date“). Any synthetic nicotine product currently on the US market as of April 14, 2022, can remain on the market for an additional 30 days until May 14, 2022 (the “Synthetic Nicotine PMTA Submission Deadline“). Manufacturers of synthetic nicotine products wishing to take advantage of FDA’s compliance policy and enforcement discretion after that date must submit a premarket tobacco product application (PMTA) to FDA by the enforcement date. If a PMTA is submitted in a timely manner, the product (s) may remain on the market for an additional 90 days after the effective date, ieuntil July 13, 2022. After July 13, 2022, any synthetic nicotine product not authorized by FDA must come off the market.

EVENT DATE NOTEBOOK
Bill Enactment March 15, 2022
Effective Date April 14, 2022

Deadline for any new* synthetic nicotine products to enter the market

Deadline for modified synthetic nicotine products to remain on the market

Synthetic Nicotine PMTA Submission Deadline May 14, 2022 (Saturday) Deadline for submitting PMTAs for all synthetic nicotine products on the US market as of the Effective Date
Final date July 13, 2022 (Wednesday) Deadline for unauthorized synthetic nicotine products to remain on the US market

Notably, under the provision, a synthetic version of an existing nicotine product that went through the PMTA process and is now subject to a Refuse-to-Accept (RTA), Refuse-to-File (RTF), Marketing Denial Order (MDO) , or withdrawal of a marketing order may not be marketed beyond the effective date, ie, April 14, 2022. In other words, products originally formulated with tobacco-derived nicotine that were refused or denied authorization by FDA, then modified to use synthetic nicotine instead (and that is the only modification), will effectively be banned on April 13, 2022. Manufacturers of these products will not be given an opportunity to submit a new PMTA. This appears to be Congress’s way of doubling down on products that, in Congress’ view, switched to synthetic nicotine to get around the PMTA process.

Beyond the PMTA submission requirement, manufacturers of synthetic nicotine products will be subject to all requirements of regulations for tobacco products. This likely includes all other Tobacco Control Act requirements, including tobacco product establishment registration and product listing; ingredient listing; label compliance; and health document submissions, among others. We anticipate that FDA will provide guidance on deadlines for these requirements in the near future.

By admin

Leave a Reply

Your email address will not be published.